What we do TTK Healthcare Ltd is an Indian healthcare company offering pharmaceuticals, consumer products, medical devices, protective devices, and foods, known for Woodward's Gripewater. |
Founded in 1,958 |
Market share Leader in multiple healthcare segments with diversified presence across India and select export markets. |
Problem solved Delivers healthcare and consumer wellness solutions including cardiac care, animal health, and protective devices addressing diverse consumer and medical needs. |
Top clients or who we serve Serves consumers, hospitals, veterinary markets, and government programs with B2B, B2C, and B2G focus. |
Key management S Kalyanaraman - Managing Director & CEO with strong leadership guiding company growth. |
Our journey and innovations Over six decades of product innovation and business expansion including strategic partnerships and multiple new product launches across segments. |
Where we operate Primarily India with exports to UK, Egypt, US, Germany, Singapore, Malaysia, Caribbean countries. |
Top products or what we offer Woodward's Gripewater, Skore condoms, EVA deodorants, orthopedic implants, animal welfare products, ready-to-fry snacks. |
Top brands Woodward's Gripewater - iconic legacy brand; Skore - fast-growing in contraceptives; EVA - award-winning deodorant; Good Home clean home range. |
Raw materials needed Pharmaceutical compounds, latex, food-grade materials, medical device components, agro-ingredients for animal products. |
Raw materials supplier Varied suppliers domestically and internationally, including specialized partners for medical and chemical inputs. |
Recurring vs cyclical contribution Revenue mostly recurring through consumer products and medical devices; some cyclicality in foods and exports. |
Our industry position Strong market position in healthcare, contraceptives, and animal welfare; growing footprint in medical devices and consumer wellness. |
Financial highlights FY 2024-25 revenues at Rs 801.49 crores; net profit Rs 81.66 crores; steady 6% revenue growth with robust profitability. |
Geographical revenue split ~89% revenue from India; ~11% from international markets including Europe, Americas, and Asia. |
Order book - |
Whats driving growth Innovative product launches, enhanced distribution, expansion in medical devices, growing pet care, and government health initiatives. |
Our future plans Capex of ~Rs 10 crores planned; focus on product mix optimization, export growth, digital marketing, and new product development. |
Our green promise ISO 14002 environmental certification; investment in wind power; sustainability initiatives ongoing across operations. |
Our people and values Staff of 1,508 fostering innovation, diversity and a high-performance culture recognized as a 'Great Place to Work'. |
Key challenges ahead Raw material cost volatility, regulatory risks, market competition, and dependency on certain export contracts. |
Interesting facts Over 65 years of legacy with historic brands; awarded Nielsen Breakthrough Innovation; early adopter of ethical pharma products. |
Risks and strategy Mitigates input cost risks, supply chain disruptions via diversification; focuses on brand building and expanding digital and export channels. |
